Table 1

Overview of all unbalanced chromosomal alterations in bilateral breast cancer determined by comparative genomic hybridisation

CaseChromosomal gainsChromosomal losses
4598A1q22
4598B8q8pter–21; 12q22–ter; 16q21–ter
4599A1q16q
4599B16q
4600A1163pter–13; 13q11–31
4600B21q; 8q6q24–ter; 8pter–21
4601A1q2q23–ter; 6q;18q
4601B6q11–16; 16q12.1–ter
4602A21q21–ter16q12.2–ter
4602A31q21–ter16q
4602B1q21–ter16q12.2–ter
4603A11q21–ter; 16q22–ter; 22q11.2–ter
4603B18q2q22–32; 7q; 16q12.2–ter; 22q12–ter
4604A1q21–ter; 8p21–11.1; 14q11.1–22; 17q; 20; 226q; 11q13–ter
4604B3pter–24; 8q; 11p14–11.12q; 6q14–ter; 17p
4644A1q; 3; 5p14–11; 7; 8; 10pter–11.2; 11; 20; 215q13–ter; 9; 14q; 18
4644B1q21-ter2q14.2–24; 4p; 16q12.2–ter; 17p; 22
4790A28q8pter–22; 16q21–ter
4790B1q16q; 22p
4791A1; 4p; 6p; 11q14-ter; 15q11.2-15; 202; 3pter–22; 4q21–ter; 6q; 11q14–ter; 13q; 18; 21
4791B1q2q11.1–32; 6p23–qter; 8p; 16q
4793A216q; 17; 22q
4793B206q; 22qter
4795A1q6q16–ter; 11q21–ter; 16q
4795B1q; 11q12–13; 17q11.1–21
4796A8q; 172q22–32; 6q; 13q
4796B206q
4797A1q16q
4797B1q3p22–14; 8pter–12; 16q
4798A1q; 8q8p; 17p; 18
4798B11q11q14–ter; 16q; 17pter–q12
4799A1q; 5p; 7; 17q21–ter11q13–ter; 12p; 17p; 18
4799B28p21–qter; 12pter–q21; 13q11–218pter–22; 10q11.1–23; 11q14–ter; 12q23–ter; 16q